XML 50 R71.htm IDEA: XBRL DOCUMENT v2.4.0.6
Share-Based Compensation, Stock Options (Details) (USD $)
In Millions, except Share data, unless otherwise specified
12 Months Ended 0 Months Ended 12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2012
Stock Options [Member]
Dec. 31, 2011
Stock Options [Member]
Dec. 31, 2010
Stock Options [Member]
Mar. 01, 2010
Stock Options [Member]
Market-based Award [Member]
Tranches
days
Dec. 31, 2012
Stock Option and Performance Award Plan 2008 [Member]
Dec. 31, 2012
Stock Option and Performance Award Plan 1991 [Member]
Dec. 31, 2012
Minimum [Member]
Stock Options [Member]
Dec. 31, 2012
Maximum [Member]
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Closing Market Price               100.00%      
Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Average Market Price                 100.00%    
Vesting Period                   3 years 5 years
Contractual term (years)       10 years              
Number of tranches             3        
Target price number one             $ 38.95        
Target price number two             $ 42.85        
Target price number three             $ 47.14        
Market condition, number of trading days             30        
Expected dividend yield       0.00% 0.00% 0.00%          
Expected volatility       46.59% 45.40% 43.43%          
Risk-free interest rate       0.46% 1.29% 2.83%          
Expected term (years)       6 years 6 years 6 years 6 months          
Weighted-average grant date fair value of stock options granted       $ 29.45 $ 23.39 $ 15.96          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]                      
Options outstanding, number of shares, beginning of period       501,636              
Options, weighted-average exercise price per share, beginning of period       $ 29.81              
Granted, number of shares       69,552     190,300        
Granted, weighted-average exercise price       $ 66.99              
Exercised, number of shares (141,728) (158,440) (480,514) (201,704)              
Exercised, weighted-average exercise price per share       $ 17.12              
Forfeited or expired, number of shares       (1,413)              
Forfeited or expired, weighted-average exercise price per share       $ 59.87              
Options outstanding, number of shares, end of period       368,071 501,636            
Options, weighted-average exercise price per share, end of period       $ 43.67 $ 29.81            
Options outstanding, weighted-average remaining contractual term       6 years 11 months 19 days              
Options outstanding, aggregate intrinsic value       $ 14.7              
Vested and expected to vest, number of shares       363,782              
Vested and expected to vest, weighted-average exercise price per share       $ 43.55              
Vested and expected to vest, weighted-average remaining contractual term       6 years 11 months 16 days              
Vested and expected to vest, aggregate intrinsic value       14.5              
Exercisable, number of shares       222,486              
Exercisable, weighted-average exercise price per share       $ 34.43              
Exercisable, weighted-average remaining contractual term       6 years 1 month 2 days              
Exercisable, aggregate intrinsic value       10.9              
Compensation expense       1.8 2.2 2.7          
Income tax benefit recognized in the income statement       0.7 0.8 1.0          
Aggregate grant-date fair value of stock options vested       1.3 1.1 2.0          
Intrinsic value of stock options exercised       12.1 9.5 21.7          
Cash received from option exercises       1.9 2.1 2.1          
Tax benefit realized from options exercised during the annual period       4.6 0.2 1.2          
Unrecognized compensation cost relating to nonvested stock options       $ 1.2              
Unrecognized compensation cost weighted-average period of recognition       12 months              
Shares available for future grants       1,331,896